Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 855

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 855
---
 recorded in other income (expense) in the Statement of Operations. The fair value measurement as of September 30, 2023 was approximately $2.1 million. The following table provides a summary of the changes in the fair value of the rights from Private Placement measured using Level 3 inputs:

|                                                       |     | Nine Months Ended 
 September 30,     
 2024              
 (in thousands)    |        |   |     | 2023 |       |   |
|:------------------------------------------------------|:----|:------------------|-------:|:--|:----|:-----|------:|:--|
| Balance at beginning of period                        |     | $                 |  3,832 |   |     | $    | 2,250 |   |
| Change in fair value of rights from Private Placement |     |                   | (3,832 | ) |     |      |  (180 | ) |
| Balance at end of period                              |     | $                 |      — |   |     | $    | 2,070 |   |

2020 Notes The Company elected the fair value option to account for the 2020 notes (as defined below) (see Note 5). During 2024, the Company did not obtain an independent valuation of the 2020 notes as they matured on July 31, 2024 and the fair value approximates the principal amount. The 2020 notes matured on July 31, 2024 and are payable anytime after the maturity date upon demand by the holder. The 2020 notes were valued using a discounted cash flow model based on the contractual payment dates, a discount rate and the contractual maturity date. The significant unobservable inputs used in the fair value measurement of the 2020 notes for the three months ended September 30, 2023 were as follows: discount rate of 14.0% and contractual payment date of 0.8 year, which resulted in a fair value for the 2020 note of $236,000. The following table provides a summary of the changes in the fair value of the 2020 notes payable measured using Level 3 inputs:

|                                    |     | Nine Months Ended 
 September 30,     
 2024              
 (in thousands)    |     |     | 2023 |     |
|:-----------------------------------|:----|:------------------|----:|:----|:-----|----:|
| Balance at beginning of period